Literature DB >> 6469081

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

B K Sharma, R P Walt, R E Pounder, M D Gomes, E C Wood, L H Logan.   

Abstract

In a series of 59 experiments in nine duodenal ulcer patients, 24 hour intragastric acidity was measured before, during, and after treatment with daily oral omeprazole. Omeprazole 10, 20, and 30 mg/day for one week caused a 37, 90, and 97% decrease of 24 hour intragastric acidity, respectively. No further decrease of acidity was observed when the dose of omeprazole was doubled to 60 mg/day, or after a second week of treatment with 30 mg/day. One week after stopping treatment with omeprazole (14 doses) there was a significant 26% decrease of 24 hour intragastric acidity, with full recovery seven weeks later. Fasting plasma gastrin concentration was significantly raised during treatment with all doses of omeprazole. Omeprazole 30 mg/day is the optimal dose for a maximal decrease of 24 hour intragastric acidity in duodenal ulcer patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469081      PMCID: PMC1432495          DOI: 10.1136/gut.25.9.957

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  A nonelectrogenic H+ pump in plasma membranes of hog stomach.

Authors:  G Sachs; H H Chang; E Rabon; R Schackman; M Lewin; G Saccomani
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

2.  The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer.

Authors:  C T Richardson; J H Walsh; M I Hicks
Journal:  Gastroenterology       Date:  1976-07       Impact factor: 22.682

3.  Effects of long-term cimetidine on serum gastrin in duodenal ulcer.

Authors:  J Hansky; A I Stern; M G Korman; J Waugh
Journal:  Dig Dis Sci       Date:  1979-06       Impact factor: 3.199

4.  Omeprazole and liver function tests.

Authors:  B K Sharma; I A Santana; R P Walt; R E Pounder
Journal:  Lancet       Date:  1983-08-06       Impact factor: 79.321

5.  Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans.

Authors:  L Olbe; U Haglund; R Leth; T Lind; C Cederberg; G Ekenved; B Elander; E Fellenius; P Lundborg; B Wallmark
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

6.  24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine.

Authors:  R E Pounder; R H Hunt; S H Vincent; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

7.  24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

8.  Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.

Authors:  A Giacosa; R Cheli; F Molinari; M C Parodi
Journal:  Scand J Gastroenterol Suppl       Date:  1982

9.  Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.

Authors:  R P Walt; P J Male; J Rawlings; R H Hunt; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

10.  Characterization of gastric mucosal membranes. X. Immunological studies of gastric (H+ + K+)-ATPase.

Authors:  G Saccomani; H F Helander; S Crago; H H Chang; D W Dailey; G Sachs
Journal:  J Cell Biol       Date:  1979-11       Impact factor: 10.539

View more
  65 in total

1.  Acid suppression.

Authors:  R H Hunt
Journal:  BMJ       Date:  1990-11-03

2.  Acid suppression.

Authors: 
Journal:  BMJ       Date:  1990-12-08

3.  Omeprazole in gastric and duodenal ulcers.

Authors:  V Savarino; G S Mela; G Celle
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

4.  Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach?

Authors:  Helge L Waldum; Tom C Martinsen; Oyvind Hauso; Gunnar Qvigstad
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

5.  Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.

Authors:  J Theisen; D Nehra; D Citron; J Johansson; J A Hagen; P F Crookes; S R DeMeester; C G Bremner; T R DeMeester; J H Peters
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

6.  Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.

Authors:  M J Levy; C B Seelig; N J Robinson; J E Ranney
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

7.  Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens.

Authors:  L C Baak; J B Jansen; I Biemond; C B Lamers
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  A long lasting gastrin response to apomorphine revealed by inhibitors of gastric acid secretion.

Authors:  M Goiny; K Brodin; C E Elwin; K Uvnäs-Moberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

9.  Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo.

Authors:  K D Bardhan; P Cherian; A Vaishnavi; R B Jones; M Thompson; P Morris; A Brooks; J D'Silva; K R Gillon; C Wason; J Patterson; J Polak; A Bishop
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

10.  Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole.

Authors:  B K Sharma; I A Santana; E C Wood; R P Walt; M Pereira; P Noone; P L Smith; C L Walters; R E Pounder
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.